Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FZ99Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,528
Award facts
- Contract value 100% obligated
- $47,528.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pen injectors in 0.5 mL quantities. This competitively awarded, non-set-aside contract carries a ceiling value of $47,528.36 and is structured as a firm fixed-price delivery order, with an ultimate completion date of December 17, 2025. The product will be sourced from and performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio of federal contract awards with the Defense Logistics Agency demonstrates its capability to supply a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. As a prime contractor under the DLA's pharmaceutical supply chain, AmerisourceBergen fulfills orders for specialty medications, brand-name and generic drugs, and medical devices to support the Defense Health Agency and other government healthcare systems. This delivery order reflects the company's ongoing role in supplying essential medications to federal military healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FZ99Z?
SPE2DR26FZ99Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FZ99Z worth?
The government has obligated $47,528 on SPE2DR26FZ99Z.
Is contract SPE2DR26FZ99Z an order under another contract?
Yes. SPE2DR26FZ99Z is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FZ99Z competed?
The extent of competition for SPE2DR26FZ99Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award